Adenotonsillectomy improves most children with pediatric obstructive sleep apnea, although residual disease remains common.
Pediatric obstructive sleep apnea (OSA) affects approximately 2-5% of children. Adenotonsillectomy is the first-line therapy and improves most patients, but residual disease is common.
Evidence Score
Study Evidence
Study 1. Current and Emerging Therapies for Pediatric Sleep Disorders: A Narrative Review.
observationalEstrada Chaverri L, DelRosso LM, Ceballos Fuentes FA · Neurology and therapy (2026)
Result:
Mechanism Graph
Limitations
- ⚠Residual disease remains common after surgery
- ⚠Long-term outcomes and comparative efficacy versus other treatments not detailed in abstract
Frequently Asked Questions
What is the first-line treatment for pediatric obstructive sleep apnea?▼
Adenotonsillectomy is the first-line therapy for pediatric OSA.
Does adenotonsillectomy cure all children with sleep apnea?▼
No, while most children improve, residual disease remains common after surgery.
What percentage of children are affected by obstructive sleep apnea?▼
Pediatric OSA affects approximately 2-5% of children.
What are adjunctive treatments for pediatric OSA?▼
Adjunctive treatments include intranasal corticosteroids, leukotriene receptor antagonists, positive airway pressure therapy, and emerging approaches like high-flow nasal cannula.
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Estrada Chaverri L, DelRosso LM, Ceballos Fuentes FA. "Current and Emerging Therapies for Pediatric Sleep Disorders: A Narrative Review.." Neurology and therapy, 2026. PMID: 42525367 DOI: 10.1007/s40120-026-01002-1